Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Avexxin logo — Crafting innovative treatments rooted in over a decade of re...

Avexxin

Crafting innovative treatments rooted in over a decade of research into inflammatory diseases.

Founded 2005 2 employees Venture round Biotechnology, Pharmaceutical

General Information

Company Name Avexxin
Founded Year 2005
Employees 2
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Avexxin. To contact Avexxin, visit avexxin.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Avexxin compare?

A PDF of Avexxin and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Avexxin soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Avexxin

Avexxin is a biotechnology and pharmaceutical startup founded in 2005. With a slogan of "Crafting innovative treatments rooted in over a decade of research into inflammatory diseases," the company has garnered attention for its pioneering approach to therapeutic methodology. Leveraging over ten years of research into the biological processes involved in inflammatory diseases at the Norwegian University of Science and Technology, Avexxin is dedicated to discovering and developing groundbreaking treatments that target the fundamental mechanisms underlying inflammatory diseases. The company's commitment to innovation has attracted significant attention, with the latest Venture Round investment taking place on 10 January 2011, with contributions from Leiv Eiriksson Nyskaping AS and Sarsia Seed Management.

Business keywords: Inflammatory Diseases, Therapeutic Methodology, Biological Processes, Research, Drug Discovery, Biological Mechanisms, Therapeutic Company, Biomedical Innovation, Norwegian University of Science and Technology, Innovative Treatments

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
Leiv Eiriksson Nyskaping AS Sarsia Seed Management
Leiv Eiriksson Nyskaping AS, Sarsia Seed Management
10 Jan 2011

Avexxin Alternatives & Competitors

View All Alternatives
Avexxin vs
Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals

Crafting the future of medicine by harnessing the body’s natural ability to resolve inflammation nat...

Venture round
11-50 employees
Biotechnology, Health and Wellness
Avexxin vs
EOLO PHARMA
EOLO PHARMA United States

Cutting-Edge Pharmacological Treatment for Obesity

Venture round
12 employees
Biopharma, Biotechnology
Avexxin vs
Laminar Pharma
Laminar Pharma Spain

Biopharmaceutical company performing discovery, rational design and initial clinical development of...

39 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Avexxin

Crafting innovative treatments rooted in over a decade of research into inflammatory diseases.
Avexxin was founded in 2005.
Avexxin operates in Biotechnology and Pharmaceutical. Its work centres on Inflammatory Diseases, Therapeutic Methodology, Biological Processes and Research.
Avexxin has approximately 2 employees.
Avexxin has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Avexxin include Resolvyx Pharmaceuticals, EOLO PHARMA, Laminar Pharma, LYNK Pharmaceuticals, OPPILOTECH LTD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avexxin and Resolvyx Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Avexxin, https://bouncewatch.com/company/avexxin, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout